7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders

Neurochemistry International

Volumn 89, Issue , 2015, Pages 170-180

  Du, X ^a   Hill, R A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

7,8 dihydroxyflavone; BDNF; Cognition; Flavonoids; Neurodevelopmental disorders; TrkB

Indexed keywords

7,8 DIHYDROXYFLAVONE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; 6,7-DIHYDROXYFLAVONE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; FLAVONE DERIVATIVE; NERVE GROWTH FACTOR;

AUTISM; BRAIN DEVELOPMENT; DEVELOPMENTAL DISORDER; FETAL ALCOHOL SYNDROME; HUMAN; NERVE CELL DIFFERENTIATION; NEURODEVELOPMENTAL DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; RUBINSTEIN SYNDROME; SCHIZOPHRENIA; ANIMAL; DRUG EFFECTS; METABOLISM; NEURODEVELOPMENTAL DISORDERS; PHYSIOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FLAVONES; HUMANS; NERVE GROWTH FACTORS; NEURODEVELOPMENTAL DISORDERS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84942292838     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.07.021     Document Type: Review

References (217)

1. M.W. Abdallah, E.L. Mortensen, K. Greaves-Lord, N. Larsen, E.C. Bonefeld-Jorgensen, B. Norgaard-Pedersen, and J. Grove Neonatal levels of neurotrophic factors and risk of autism spectrum disorders Acta Psychiatr. Scand. 128 1 2013 61 69 10.1111/acps.12020
2. T. Aid, A. Kazantseva, M. Piirsoo, K. Palm, and T. Timmusk Mouse and rat BDNF gene structure and expression revisited J. Neurosci. Res. 85 3 2007 525 535 10.1002/jnr.21139
3. L.Y. Al-Ayadhi Relationship between sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders Neurochem. Res. 37 2 2012 394 400 10.1007/s11064-011-0624-x
4. D.G. Amaral, C.M. Schumann, and C.W. Nordahl Neuroanatomy of autism Trends Neurosci. 31 3 2008 137 145 10.1016/j.tins.2007.12.005
5. M.D. Amaral, C.A. Chapleau, and L. Pozzo-Miller Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome Pharmacol. Ther. 113 2 2007 394 409 10.1016/j.pharmthera.2006.09.005
6. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet. 23 2 1999 185 188 10.1038/13810
7. R. Andero, N. Daviu, R.M. Escorihuela, R. Nadal, and A. Armario 7,8-dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats Hippocampus 22 3 2012 399 408 10.1002/hipo.20906
8. R. Andero, S.A. Heldt, K. Ye, X. Liu, A. Armario, and K.J. Ressler Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning Am. J. Psychiatry 168 2 2011 163 172 10.1176/appi.ajp.2010.10030326
9. A.E. Autry, and L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol. Rev. 64 2 2012 238 258 10.1124/pr.111.005108
10. S. Balaratnasingam, and A. Janca Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders Pharmacol. Ther. 134 1 2012 116 124 10.1016/j.pharmthera.2012.01.006
11. A.J. Bannister, and T. Kouzarides The CBP co-activator is a histone acetyltransferase Nature 384 6610 1996 641 643 10.1038/384641a0
12. Y.A. Barde, D. Edgar, and H. Thoenen Purification of a new neurotrophic factor from mammalian brain EMBO J. 1 5 1982 549 553
13. R.V. Behere, R. Arasappa, A. Jagannathan, S. Varambally, G. Venkatasubramanian, J. Thirthalli, and B.N. Gangadhar Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia Acta Psychiatr. Scand. 123 2 2011 147 153 10.1111/j.1600-0447.2010.01605.x
14. R. Bernier, C. Golzio, B. Xiong, H.A. Stessman, B.P. Coe, O. Penn, and E.E. Eichler Disruptive CHD8 mutations define a subtype of autism early in development Cell 158 2 2014 263 276 10.1016/j.cell.2014.06.017
15. E. Bollen, T. Vanmierlo, S. Akkerman, C. Wouters, H.M. Steinbusch, and J. Prickaerts 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice Behav. Brain Res. 257 2013 8 12 10.1016/j.bbr.2013.09.029
16. S. Bolognin, J. Blanchard, X. Wang, G. Basurto-Islas, Y.C. Tung, E. Kohlbrenner, and K. Iqbal An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide Acta Neuropathol. 123 1 2012 133 151 10.1007/s00401-011-0908-x
17. F. Boulle, D.L. van den Hove, S.B. Jakob, B.P. Rutten, M. Hamon, J. van Os, and G. Kenis Epigenetic regulation of the BDNF gene: implications for psychiatric disorders Mol. Psychiatry 17 6 2012 584 596 10.1038/mp.2011.107
18. R.T. Brown, C.D. Coles, I.E. Smith, K.A. Platzman, J. Silverstein, S. Erickson, and A. Falek Effects of prenatal alcohol exposure at school age. II. Attention and behavior Neurotoxicol Teratol. 13 4 1991 369 376
19. V.L. Buchman, and A.M. Davies Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons Development 118 3 1993 989 1001
20. K.K. Caldwell, S. Sheema, R.D. Paz, S.L. Samudio-Ruiz, M.H. Laughlin, and N.E. Spence A.M. Allan Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model Pharmacol. Biochem. Behav. 90 4 2008 614 624 10.1016/j.pbb.2008.05.004
21. J.P. Chan, J. Cordeira, G.A. Calderon, L.K. Iyer, and M. Rios Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampus Mol. Cell Neurosci. 39 3 2008 372 383 10.1016/j.mcn.2008.07.017
22. Q. Chang, G. Khare, V. Dani, S. Nelson, and R. Jaenisch The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression Neuron 49 3 2006 341 348 10.1016/j.neuron.2005.12.027
23. H.M. Chao, H.T. Kao, and B. Porton BDNF Val66Met variant and age of onset in schizophrenia Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B 4 2008 505 506 10.1002/ajmg.b.30619
24. C.A. Chapleau, G.D. Calfa, M.C. Lane, A.J. Albertson, J.L. Larimore, S. Kudo, and L. Pozzo-Miller Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations Neurobiol. Dis. 35 2 2009 219 233 10.1016/j.nbd.2009.05.001
25. A. Chauhan, V. Chauhan, W.T. Brown, and I. Cohen Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins Life Sci. 75 21 2004 2539 2549 10.1016/j.lfs.2004.04.038
26. C.C. Chen, and T.L. Huang Effects of antipsychotics on the serum BDNF levels in schizophrenia Psychiatry Res. 189 3 2011 327 330 10.1016/j.psychres.2011.01.011
27. C. Chen da, J. Wang, B. Wang, S.C. Yang, C.X. Zhang, Y.L. Zheng, and X.Y. Zhang Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes Psychopharmacol. Berl. 207 3 2009 375 380 10.1007/s00213-009-1665-6
28. X. Chen, C.D. Coles, M.E. Lynch, and X. Hu Understanding specific effects of prenatal alcohol exposure on brain structure in young adults Hum. Brain Mapp. 33 7 2012 1663 1676 10.1002/hbm.21313
29. E.P. Cherniack A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders Br. J. Nutr. 108 5 2012 794 800 10.1017/S0007114512000669
30. C. Chiaruttini, M. Sonego, G. Baj, M. Simonato, and E. Tongiorgi BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae Mol. Cell Neurosci. 37 1 2008 11 19 10.1016/j.mcn.2007.08.011
31. S.K. Clarren, E.C. Alvord Jr., S.M. Sumi, A.P. Streissguth, and D.W. Smith Brain malformations related to prenatal exposure to ethanol J. Pediatr. 92 1 1978 64 67
32. E. Climent, M. Pascual, J. Renau-Piqueras, and C. Guerri Ethanol exposure enhances cell death in the developing cerebral cortex: role of brain-derived neurotrophic factor and its signaling pathways J. Neurosci. Res. 68 2 2002 213 225
33. S. Cohen-Cory, A.H. Kidane, N.J. Shirkey, and S. Marshak Brain-derived neurotrophic factor and the development of structural neuronal connectivity Dev. Neurobiol. 70 5 2010 271 288 10.1002/dneu.20774
34. C.D. Coles, R.T. Brown, I.E. Smith, K.A. Platzman, S. Erickson, and A. Falek Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development Neurotoxicol Teratol. 13 4 1991 357 367
35. A.M. Connolly, M. Chez, E.M. Streif, R.M. Keeling, P.T. Golumbek, J.M. Kwon, and R.M. Deuel Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy Biol. Psychiatry 59 4 2006 354 363 10.1016/j.biopsych.2005.07.004
36. C.T. Correia, A.M. Coutinho, A.F. Sequeira, I.G. Sousa, L. Lourenco Venda, J.P. Almeida, and A.M. Vicente Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism Genes Brain Behav. 9 7 2010 841 848 10.1111/j.1601-183X.2010.00627.x
37. J.A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, and Y. De Koninck BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain Nature 438 7070 2005 1017 1021 10.1038/nature04223
38. S.D. Croll, C. Suri, D.L. Compton, M.V. Simmons, G.D. Yancopoulos, R.M. Lindsay, and H.E. Scharfman Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex Neuroscience 93 4 1999 1491 1506
39. C. Cunha, A. Angelucci, A. D'Antoni, M.D. Dobrossy, S.B. Dunnett, N. Berardi, and R. Brambilla Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments Neurobiol. Dis. 33 3 2009 358 368 10.1016/j.nbd.2008.11.004
40. U.N. Das Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids Nutrition 29 10 2013 1175 1185 10.1016/j.nut.2013.01.012
41. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev. 13 22 1999 2905 2927
42. L. Devi, and M. Ohno 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease Neuropsychopharmacology 37 2 2012 434 444 10.1038/npp.2011.191
43. R.S. Duman Role of neurotrophic factors in the etiology and treatment of mood disorders Neuromolecular Med. 5 1 2004 11 25 10.1385/NMM:5:1:011
44. N. Durany, T. Michel, R. Zochling, K.W. Boissl, F.F. Cruz-Sanchez, P. Riederer, and J. Thome Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses Schizophr. Res. 52 1-2 2001 79 86
45. M. Ebadi, S.K. Srinivasan, and M.D. Baxi Oxidative stress and antioxidant therapy in Parkinson's disease Prog. Neurobiol. 48 1 1996 1 19
46. P. Ernfors, K.F. Lee, and R. Jaenisch Mice lacking brain-derived neurotrophic factor develop with sensory deficits Nature 368 6467 1994 147 150 10.1038/368147a0
47. M.D. Failla, Y.P. Conley, and A.K. Wagner Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: Interrelationships between genetics and acute systemic and central nervous system BDNF profiles Neurorehabil Neural Repair 2015 10.1177/1545968315586465
48. M.J. Feng, S.E. Yan, and Q.S. Yan Effects of prenatal alcohol exposure on brain-derived neurotrophic factor and its receptor tyrosine kinase B in offspring Brain Res. 1042 2 2005 125 132 10.1016/j.brainres.2005.02.017
49. J.M. Ferguson SSRI antidepressant medications: adverse effects and tolerability Prim. Care Comp. J. Clin. Psychiatry 3 1 2001 22 27
50. F. Fumagalli, F. Calabrese, A. Luoni, F. Bolis, G. Racagni, and M.A. Riva Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress Int. J. Neuropsychopharmacol. 15 2 2012 235 246 10.1017/S1461145711000150
51. V. Georgiev, A. Ananga, and V. Tsolova Recent advances and uses of grape flavonoids as nutraceuticals Nutrients 6 1 2014 391 415 10.3390/nu6010391
52. S.M. Gibney, B. McGuinness, C. Prendergast, A. Harkin, and T.J. Connor Poly I: C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression Brain Behav. Immun. 28 2013 170 181 10.1016/j.bbi.2012.11.010
53. C.R. Goodlett, K.H. Horn, and F.C. Zhou Alcohol teratogenesis: mechanisms of damage and strategies for intervention Exp. Biol. Med. Maywood 230 6 2005 394 406
54. L.J. Goodman, J. Valverde, F. Lim, M.D. Geschwind, H.J. Federoff, A.I. Geller, and F. Hefti Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons Mol. Cell Neurosci. 7 3 1996 222 238 10.1006/mcne.1996.0017
55. R.H. Goodman, and S. Smolik CBP/p300 in cell growth, transformation, and development Genes Dev. 14 13 2000 1553 1577
56. R. Gotz, F. Raulf, and M. Schartl Brain-derived neurotrophic factor is more highly conserved in structure and function than nerve growth factor during vertebrate evolution J. Neurochem. 59 2 1992 432 442
57. M.J. Green, S.L. Matheson, A. Shepherd, C.S. Weickert, and V.J. Carr Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis Mol. Psychiatry 16 9 2011 960 972 10.1038/mp.2010.88
58. R.W. Grillo, G.L. Ottoni, R. Leke, D.O. Souza, L.V. Portela, and D.R. Lara Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics J. Psychiatr. Res. 41 1-2 2007 31 35 10.1016/j.jpsychires.2006.01.005
59. C. Guo, Y. Yang, Y. Su, and T. Si Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration J. Biomed. Biotechnol. 2010 2010 783297 10.1155/2010/783297
60. B. Hagberg, J. Aicardi, K. Dias, and O. Ramos A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases Ann. Neurol. 14 4 1983 471 479 10.1002/ana.410140412
61. T.M. Hallam, and R. Bourtchouladze Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction Cell Mol. Life Sci. 63 15 2006 1725 1735 10.1007/s00018-005-5555-8
62. J. Hallmayer, S. Cleveland, A. Torres, J. Phillips, B. Cohen, T. Torigoe, and N. Risch Genetic heritability and shared environmental factors among twin pairs with autism Arch. Gen. Psychiatry 68 11 2011 1095 1102 10.1001/archgenpsychiatry.2011.76
63. J.B. Harborne, and C.A. Williams Advances in flavonoid research since 1992 Phytochemistry 55 6 2000 481 504
64. K. Hashimoto, Y. Iwata, K. Nakamura, M. Tsujii, K.J. Tsuchiya, Y. Sekine, and N. Mori Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism Prog. Neuropsychopharmacol. Biol. Psychiatry 30 8 2006 1529 1531 10.1016/j.pnpbp.2006.06.018
65. M. Hetman, K. Kanning, J.E. Cavanaugh, and Z. Xia Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase J. Biol. Chem. 274 32 1999 22569 22580
66. R.A. Hill, Y.W. Wu, A. Gogos, and M. van den Buuse Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones J. Neurochem. 126 3 2013 389 399 10.1111/jnc.12205
67. B.C. Ho, P. Milev, D.S. O'Leary, A. Librant, N.C. Andreasen, and T.H. Wassink Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers Arch. Gen. Psychiatry 63 7 2006 731 740 10.1001/archpsyc.63.7.731
68. Y. Hou, M.A. Aboukhatwa, D.L. Lei, K. Manaye, I. Khan, and Y. Luo Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice Neuropharmacology 58 6 2010 911 920 10.1016/j.neuropharm.2009.11.002
69. E.J. Huang, and L.F. Reichardt Trk receptors: roles in neuronal signal transduction Annu. Rev. Biochem. 72 2003 609 642 10.1146/annurev.biochem.72.121801.161629
70. T.L. Huang, and C.T. Lee Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients J. Psychiatr. Res. 40 7 2006 664 668 10.1016/j.jpsychires.2005.11.004
71. Y. Ikeda, N. Yahata, I. Ito, M. Nagano, T. Toyota, T. Yoshikawa, and H. Suzuki Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia Schizophr. Res. 101 1-3 2008 58 66 10.1016/j.schres.2008.01.017
72. T. Inagaki, T. Begum, F. Reza, S. Horibe, M. Inaba, Y. Yoshimura, and Y. Komatsu Brain-derived neurotrophic factor-mediated retrograde signaling required for the induction of long-term potentiation at inhibitory synapses of visual cortical pyramidal neurons Neurosci. Res. 61 2 2008 192 200 10.1016/j.neures.2008.02.006
73. I. Iossifov, B.J. O'Roak, S.J. Sanders, M. Ronemus, N. Krumm, D. Levy, and M. Wigler The contribution of de novo coding mutations to autism spectrum disorder Nature 515 7526 2014 216 221 10.1038/nature13908
74. C. Isgor, C. Pare, B. McDole, P. Coombs, and K. Guthrie Expansion of the dentate mossy fiber-CA3 projection in the brain-derived neurotrophic factor-enriched mouse hippocampus Neuroscience 288 2015 10 23 10.1016/j.neuroscience.2014.12.036
75. T. Itahashi, T. Yamada, M. Nakamura, H. Watanabe, B. Yamagata, D. Jimbo, and R. Hashimoto Linked alterations in gray and white matter morphology in adults with high-functioning autism spectrum disorder: a multimodal brain imaging study Neuroimage Clin. 7 2015 155 169 10.1016/j.nicl.2014.11.019
76. S. Jacot-Descombes, N. Uppal, B. Wicinski, M. Santos, J. Schmeidler, P. Giannakopoulos, and P.R. Hof Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism Acta Neuropathol. 124 1 2012 67 79 10.1007/s00401-012-0976-6
77. S.W. Jang, X. Liu, M. Yepes, K.R. Shepherd, G.W. Miller, Y. Liu, and K. Ye A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc. Natl. Acad. Sci. U. S. A. 107 6 2010 2687 2692 10.1073/pnas.0913572107
78. R.A. Johnson, M. Lam, A.M. Punzo, H. Li, B.R. Lin, K. Ye, and Q. Chang 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome J. Appl. Physiol. (1985) 112 5 2012 704 710 10.1152/japplphysiol.01361.2011
79. K.R. Jones, and L.F. Reichardt Molecular cloning of a human gene that is a member of the nerve growth factor family Proc. Natl. Acad. Sci. U. S. A. 87 20 1990 8060 8064
80. E.A. Joosten, and D.A. Houweling Local acute application of BDNF in the lesioned spinal cord anti-inflammatory and anti-oxidant effects Neuroreport 15 7 2004 1163 1166
81. A. Kaminitz, R. Barzilay, H. Segal, M. Taler, D. Offen, I. Gil-Ad, and A. Weizman Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression World J. Biol. Psychiatry 15 1 2014 76 82 10.3109/15622975.2013.841993
82. K.A. Kang, Z.H. Wang, R. Zhang, M.J. Piao, K.C. Kim, S.S. Kang, and J.W. Hyun Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathways Int. J. Mol. Sci. 11 11 2010 4348 4360 10.3390/ijms11114348
83. F. Karege, M. Schwald, and M. Cisse Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets Neurosci. Lett. 328 3 2002 261 264
84. N.J. Kasarpalkar, S.T. Kothari, and U.P. Dave Brain-derived neurotrophic factor in children with autism spectrum disorder Ann. Neurosci. 21 4 2014 129 133 10.5214/ans.0972.7531.210403
85. R. Katoh-Semba, R. Wakako, T. Komori, H. Shigemi, N. Miyazaki, H. Ito, and A. Nakayama Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls Int. J. Dev. Neurosci. 25 6 2007 367 372 10.1016/j.ijdevneu.2007.07.002
86. S.F. Kazim, C. Cardenas-Aguayo Mdel, M. Arif, J. Blanchard, F. Fayyaz, I. Grundke-Iqbal, and K. Iqbal Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in rats PLoS One 10 3 2015 e0118627 10.1371/journal.pone.0118627
87. D. Kimhy, J. Vakhrusheva, M.N. Bartels, H.F. Armstrong, J.S. Ballon, S. Khan, and R.P. Sloan The impact of aerobic exercise on brain-derived neurotrophic factor and neurocognition in individuals with schizophrenia: a single-blind, randomized clinical trial Schizophr. Bull. 2015 10.1093/schbul/sbv022
88. M.L. Kleiber, K. Mantha, R.L. Stringer, and S.M. Singh Neurodevelopmental alcohol exposure elicits long-term changes to gene expression that alter distinct molecular pathways dependent on timing of exposure J. Neurodev. Disord. 5 1 2013 6 10.1186/1866-1955-5-6
89. A.B. Klein, R. Williamson, M.A. Santini, C. Clemmensen, A. Ettrup, M. Rios, and S. Aznar Blood BDNF concentrations reflect brain-tissue BDNF levels across species Int. J. Neuropsychopharmacol. 14 3 2011 347 353 10.1017/S1461145710000738
90. M. Kondo, L.J. Gray, G.J. Pelka, J. Christodoulou, P.P. Tam, and A.J. Hannan Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome-Mecp2 gene dosage effects and BDNF expression Eur. J. Neurosci. 27 12 2008 3342 3350 10.1111/j.1460-9568.2008.06305.x
91. M.E. Kozisek, D. Middlemas, and D.B. Bylund Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies Pharmacol. Ther. 117 1 2008 30 51 10.1016/j.pharmthera.2007.07.001
92. A. Kozlowska, and D. Szostak-Wegierek Flavonoids-food sources and health benefits Rocz. Panstw Zakl. Hig. 65 2 2014 79 85
93. N. Kuczewski, C. Porcher, and J.L. Gaiarsa Activity-dependent dendritic secretion of brain-derived neurotrophic factor modulates synaptic plasticity Eur. J. Neurosci. 32 8 2010 1239 1244 10.1111/j.1460-9568.2010.07378.x
94. F.C. Kuo, C.H. Lee, C.H. Hsieh, P. Kuo, Y.C. Chen, and Y.J. Hung Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic patients with schizophrenia Psychiatry Res. 209 2 2013 150 154 10.1016/j.psychres.2012.11.020
95. U.E. Lang, I. Puls, D.J. Muller, N. Strutz-Seebohm, and J. Gallinat Molecular mechanisms of schizophrenia Cell Physiol. Biochem. 20 6 2007 687 702 10.1159/000110430
96. N. Lange, B.G. Travers, E.D. Bigler, M.B. Prigge, A.L. Froehlich, J.A. Nielsen, and J.E. Lainhart Longitudinal volumetric brain changes in autism spectrum disorder ages 6-35 years Autism Res. 8 1 2015 82 93 10.1002/aur.1427
97. J.L. Larimore, C.A. Chapleau, S. Kudo, A. Theibert, A.K. Percy, and L. Pozzo-Miller Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations Neurobiol. Dis. 34 2 2009 199 211 10.1016/j.nbd.2008.12.011
98. C. Lebel, S.N. Mattson, E.P. Riley, K.L. Jones, C.M. Adnams, P.A. May, and E.R. Sowell A longitudinal study of the long-term consequences of drinking during pregnancy: heavy in utero alcohol exposure disrupts the normal processes of brain development J. Neurosci. 32 44 2012 15243 15251 10.1523/JNEUROSCI.1161-12.2012
99. J. Lee, W. Duan, and M.P. Mattson Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice J. Neurochem. 82 6 2002 1367 1375
100. J.G. Lee, H.Y. Cho, S.W. Park, M.K. Seo, and Y.H. Kim Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells Prog. Neuropsychopharmacol. Biol. Psychiatry 34 6 2010 1001 1006 10.1016/j.pnpbp.2010.05.013
101. J.S. Lee, C.K. Byun, H. Kim, B.C. Lim, H. Hwang, J.E. Choi, and J.H. Chae Clinical and mutational spectrum in Korean patients with Rubinstein-Taybi syndrome: the spectrum of brain MRI abnormalities Brain Dev. 37 4 2015 402 408 10.1016/j.braindev.2014.07.007
102. C.E. Lewis, K.G. Thomas, N.C. Dodge, C.D. Molteno, E.M. Meintjes, J.L. Jacobson, and S.W. Jacobson Verbal learning and memory impairment in children with fetal alcohol spectrum disorders Alcohol Clin. Exp. Res. 39 4 2015 724 732 10.1111/acer.12671
103. W. Li, G. Calfa, J. Larimore, and L. Pozzo-Miller Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice Proc. Natl. Acad. Sci. U. S. A. 109 42 2012 17087 17092 10.1073/pnas.1205271109
104. W. Li, and L. Pozzo-Miller BDNF deregulation in Rett syndrome Neuropharmacology 76 Pt C 2014 737 746 10.1016/j.neuropharm.2013.03.024
105. R.M. Lindsay, Y.A. Barde, A.M. Davies, and H. Rohrer Differences and similarities in the neurotrophic growth factor requirements of sensory neurons derived from neural crest and neural placode J. Cell Sci. Suppl. 3 1985 115 129
106. R.M. Lindsay, H. Thoenen, and Y.A. Barde Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factor Dev. Biol. 112 2 1985 319 328
107. F. Liu, X. Zou, N. Sadovova, X. Zhang, L. Shi, L. Guo, and C. Wang Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia Int. J. Dev. Neurosci. 29 3 2011 351 358 10.1016/j.ijdevneu.2010.07.234
108. X. Liu, C.B. Chan, S.W. Jang, S. Pradoldej, J. Huang, K. He, and K. Ye A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect J. Med. Chem. 53 23 2010 8274 8286 10.1021/jm101206p
109. Y. Liu, X. Fu, N. Lan, S. Li, J. Zhang, S. Wang, and L. Zhang Luteolin protects against high fat diet-induced cognitive deficits in obesity mice Behav. Brain Res. 267 2014 178 188 10.1016/j.bbr.2014.02.040
110. N.J. Lobaugh, T. Wigal, P.L. Greene, J.L. Diaz-Granados, and A. Amsel Effects of prenatal ethanol exposure on learned persistence and hippocampal neuroanatomy in infant, weanling and adult rats Behav. Brain Res. 44 1 1991 81 86
111. B. Lu, G. Nagappan, X. Guan, P.J. Nathan, and P. Wren BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases Nat. Rev. Neurosci. 14 6 2013 401 416 10.1038/nrn3505
112. S.E. Maier, J.A. Cramer, J.R. West, and F. Sohrabji Alcohol exposure during the first two trimesters equivalent alters granule cell number and neurotrophin expression in the developing rat olfactory bulb J. Neurobiol. 41 3 1999 414 423
113. P.C. Maisonpierre, M.M. Le Beau, R. Espinosa 3rd, N.Y. Ip, L. Belluscio, S.M. de la Monte, and G.D. Yancopoulos Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations Genomics 10 3 1991 558 568
114. J.E. Malberg, and J.A. Blendy Antidepressant action: to the nucleus and beyond Trends Pharmacol. Sci. 26 12 2005 631 638 10.1016/j.tips.2005.10.005
115. D.S. Mandell, K.H. Morales, S.C. Marcus, A.C. Stahmer, J. Doshi, and D.E. Polsky Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders Pediatrics 121 3 2008 e441 448 10.1542/peds.2007-0984
116. M.L. Mansuri, P. Parihar, I. Solanki, and M.S. Parihar Flavonoids in modulation of cell survival signalling pathways Genes Nutr. 9 3 2014 400 10.1007/s12263-014-0400-z
117. P.A. May, A. Baete, J. Russo, A.J. Elliott, J. Blankenship, W.O. Kalberg, and H.E. Hoyme Prevalence and characteristics of fetal alcohol spectrum disorders Pediatrics 134 5 2014 855 866 10.1542/peds.2013-3319
118. P.A. May, D. Fiorentino, G. Coriale, W.O. Kalberg, H.E. Hoyme, A.S. Aragon, and M. Ceccanti Prevalence of children with severe fetal alcohol spectrum disorders in communities near Rome, Italy: new estimated rates are higher than previous estimates Int. J. Environ. Res. Public Health 8 6 2011 2331 2351 10.3390/ijerph8062331
119. P.A. May, and J.P. Gossage Estimating the prevalence of fetal alcohol syndrome. A summary Alcohol Res. Health 25 3 2001 159 167
120. P.A. May, J.P. Gossage, W.O. Kalberg, L.K. Robinson, D. Buckley, M. Manning, and H.E. Hoyme Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies Dev. Disabil. Res. Rev. 15 3 2009 176 192 10.1002/ddrr.68
121. C.J. McDougle, J.P. Holmes, D.C. Carlson, G.H. Pelton, D.J. Cohen, and L.H. Price A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders Arch. Gen. Psychiatry 55 7 1998 633 641
122. M.L. McPheeters, Z. Warren, N. Sathe, J.L. Bruzek, S. Krishnaswami, R.N. Jerome, and J. Veenstra-Vanderweele A systematic review of medical treatments for children with autism spectrum disorders Pediatrics 127 5 2011 e1312 1321 10.1542/peds.2011-0427
123. A. Merighi, C. Salio, A. Ghirri, L. Lossi, F. Ferrini, C. Betelli, and R. Bardoni BDNF as a pain modulator Prog. Neurobiol. 85 3 2008 297 317 10.1016/j.pneurobio.2008.04.004
124. J.K. Morse, S.J. Wiegand, K. Anderson, Y. You, N. Cai, J. Carnahan, and et al. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection J. Neurosci. 13 10 1993 4146 4156
125. D.P. Museridze, and L.G. Gegenava Effects of ethanol on neuron density in the limbic cortex of the brain and correction of evoked changes with the antioxidant Dolivin Neurosci. Behav. Physiol. 40 5 2010 553 556 10.1007/s11055-010-9296-2
126. G. Nagappan, and B. Lu Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications Trends Neurosci. 28 9 2005 464 471 10.1016/j.tins.2005.07.003
127. K.S. Nandra, and M. Agius The differences between typical and atypical antipsychotics: the effects on neurogenesis Psychiatr. Danub 24 Suppl. 1 2012 S95 S99
128. J.L. Neul, W.E. Kaufmann, D.G. Glaze, J. Christodoulou, A.J. Clarke, N. Bahi-Buisson, and A.K. Percy Rett syndrome: revised diagnostic criteria and nomenclature Ann. Neurol. 68 6 2010 944 950 10.1002/ana.22124
129. A.M. Nikolakopoulou, M.M. Meynard, S. Marshak, and S. Cohen-Cory Synaptic maturation of the Xenopus retinotectal system: effects of brain-derived neurotrophic factor on synapse ultrastructure J. Comp. Neurol. 518 7 2010 972 989 10.1002/cne.22258
130. M. Notaras, R. Hill, and M. van den Buuse A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review Neurosci. Biobehav. Rev. 51 2015 15 30 10.1016/j.neubiorev.2014.12.016
131. T. Novkovic, T. Mittmann, and D. Manahan-Vaughan BDNF contributes to the facilitation of hippocampal synaptic plasticity and learning enabled by environmental enrichment Hippocampus 25 1 2015 1 15 10.1002/hipo.22342
132. T. Numakawa, N. Adachi, M. Richards, S. Chiba, and H. Kunugi Brain-derived neurotrophic factor and glucocorticoids: reciprocal influence on the central nervous system Neuroscience 239 2013 157 172 10.1016/j.neuroscience.2012.09.073
133. M.J. O'Connor, B. Shah, S. Whaley, P. Cronin, B. Gunderson, and J. Graham Psychiatric illness in a clinical sample of children with prenatal alcohol exposure Am. J. Drug Alcohol Abuse 28 4 2002 743 754
134. D.P. Oswald, and N.A. Sonenklar Medication use among children with autism spectrum disorders J. Child. Adolesc. Psychopharmacol. 17 3 2007 348 355 10.1089/cap.2006.17303
135. F.G. Pajonk, T. Wobrock, O. Gruber, H. Scherk, D. Berner, I. Kaizl, and P. Falkai Hippocampal plasticity in response to exercise in schizophrenia Arch. Gen. Psychiatry 67 2 2010 133 143 10.1001/archgenpsychiatry.2009.193
136. A. Palomino, A. Vallejo-Illarramendi, A. Gonzalez-Pinto, A. Aldama, C. Gonzalez-Gomez, F. Mosquera, and C. Matute Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients Schizophr. Res. 86 1-3 2006 321 322 10.1016/j.schres.2006.05.028
137. P.T. Pang, and B. Lu Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF Ageing Res. Rev. 3 4 2004 407 430 10.1016/j.arr.2004.07.002
138. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 1-2 2007 54 61 10.1016/j.drudis.2006.10.013
139. W.M. Pardridge, D. Wu, and T. Sakane Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration Pharm. Res. 15 4 1998 576 582
140. E. Parker-Athill, D. Luo, A. Bailey, B. Giunta, J. Tian, R.D. Shytle, and J. Tan Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism J. Neuroimmunol. 217 1-2 2009 20 27 10.1016/j.jneuroim.2009.08.012
141. A. Patapoutian, and L.F. Reichardt Trk receptors: mediators of neurotrophin action Curr. Opin. Neurobiol. 11 3 2001 272 280
142. S.P. Patil, P.D. Jain, J.S. Sancheti, P.J. Ghumatkar, R. Tambe, and S. Sathaye Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice Neuropharmacology 86 2014 192 202 10.1016/j.neuropharm.2014.07.012
143. S.L. Patterson, T. Abel, T.A. Deuel, K.C. Martin, J.C. Rose, and E.R. Kandel Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice Neuron 16 6 1996 1137 1145
144. M. Pedrini, I. Chendo, I. Grande, M.I. Lobato, P.S. Belmonte-de-Abreu, C. Lersch, and C.S. Gama Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation Neurosci. Lett. 491 3 2011 207 210 10.1016/j.neulet.2011.01.039
145. V. Pencea, K.D. Bingaman, S.J. Wiegand, and M.B. Luskin Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus J. Neurosci. 21 17 2001 6706 6717
146. A.K. Percy, and J.B. Lane Rett syndrome: model of neurodevelopmental disorders J. Child. Neurol. 20 9 2005 718 721
147. F. Petrij, R.H. Giles, H.G. Dauwerse, J.J. Saris, R.C. Hennekam, M. Masuno, and et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP Nature 376 6538 1995 348 351 10.1038/376348a0
148. S. Pezet, and M. Malcangio Brain-derived neurotrophic factor as a drug target for CNS disorders Expert Opin. Ther. Targets 8 5 2004 391 399 10.1517/14728222.8.5.391
149. J.F. Poduslo, and G.L. Curran Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF Brain Res. Mol. Brain Res. 36 2 1996 280 286
150. D.J. Posey, K.A. Stigler, C.A. Erickson, and C.J. McDougle Antipsychotics in the treatment of autism J. Clin. Invest. 118 1 2008 6 14 10.1172/JCI32483
151. P. Pruunsild, A. Kazantseva, T. Aid, K. Palm, and T. Timmusk Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters Genomics 90 3 2007 397 406 10.1016/j.ygeno.2007.05.004
152. J.M. Ramirez, C.S. Ward, and J.L. Neul Breathing challenges in Rett syndrome: lessons learned from humans and animal models Respir. Physiol. Neurobiol. 189 2 2013 280 287 10.1016/j.resp.2013.06.022
153. P. Rasmussen, P. Brassard, H. Adser, M.V. Pedersen, L. Leick, E. Hart, and H. Pilegaard Evidence for a release of brain-derived neurotrophic factor from the brain during exercise Exp. Physiol. 94 10 2009 1062 1069 10.1113/expphysiol.2009.048512
154. D.A. Regier, W.E. Narrow, D.S. Rae, R.W. Manderscheid, B.Z. Locke, and F.K. Goodwin The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services Arch. Gen. Psychiatry 50 2 1993 85 94
155. L.F. Reichardt Neurotrophin-regulated signalling pathways Philos. Trans. R. Soc. Lond. B Biol. Sci. 361 1473 2006 1545 1564 10.1098/rstb.2006.1894
156. V. Reinhart, S.E. Bove, D. Volfson, D.A. Lewis, R.J. Kleiman, and T.A. Lanz Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder Neurobiol. Dis. 77 2015 220 227 10.1016/j.nbd.2015.03.011
157. Q. Ren, J.C. Zhang, Y. Fujita, M. Ma, J. Wu, and K. Hashimoto Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine Pharmacol. Biochem. Behav. 106 2013 124 127 10.1016/j.pbb.2013.03.016
158. A. Rett On a unusual brain atrophy syndrome in hyperammonemia in childhood Wien. Med. Wochenschr. 116 37 1966 723 726
159. S. Ricci, R. Businaro, F. Ippoliti, V.R. Lo Vasco, F. Massoni, E. Onofri, and T. Archer Altered cytokine and BDNF levels in autism spectrum disorder Neurotox. Res. 24 4 2013 491 501 10.1007/s12640-013-9393-4
160. E.N. Rizos, I. Rontos, E. Laskos, G. Arsenis, P.G. Michalopoulou, D. Vasilopoulos, and L. Lykouras Investigation of serum BDNF levels in drug-naive patients with schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 32 5 2008 1308 1311 10.1016/j.pnpbp.2008.04.007
161. M. Roceri, W. Hendriks, G. Racagni, B.A. Ellenbroek, and M.A. Riva Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus Mol. Psychiatry 7 6 2002 609 616 10.1038/sj.mp.4001036
162. T.M. Roebuck, S.N. Mattson, and E.P. Riley Behavioral and psychosocial profiles of alcohol-exposed children Alcohol Clin. Exp. Res. 23 6 1999 1070 1076
163. J.H. Roelfsema, and D.J. Peters Rubinstein-Taybi syndrome: clinical and molecular overview Expert Rev. Mol. Med. 9 23 2007 1 16 10.1017/S1462399407000415
164. J.H. Roelfsema, S.J. White, Y. Ariyurek, D. Bartholdi, D. Niedrist, F. Papadia, and D.J. Peters Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease Am. J. Hum. Genet. 76 4 2005 572 580 10.1086/429130
165. S.J. Rogers What are infant siblings teaching us about autism in infancy? Autism. Res. 2 3 2009 125 137 10.1002/aur.81
166. C. Rossi, A. Angelucci, L. Costantin, C. Braschi, M. Mazzantini, F. Babbini, and M. Caleo Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment Eur. J. Neurosci. 24 7 2006 1850 1856 10.1111/j.1460-9568.2006.05059.x
167. P. Sable, K. Dangat, A. Kale, and S. Joshi Altered brain neurotrophins at birth: consequence of imbalance in maternal folic acid and vitamin B(1)(2) metabolism Neuroscience 190 2011 127 134 10.1016/j.neuroscience.2011.05.010
168. P. Sable, A. Kale, A. Joshi, and S. Joshi Maternal micronutrient imbalance alters gene expression of BDNF, NGF, TrkB and CREB in the offspring brain at an adult age Int. J. Dev. Neurosci. 34 2014 24 32 10.1016/j.ijdevneu.2014.01.003
169. H. Scharfman, J. Goodman, A. Macleod, S. Phani, C. Antonelli, and S. Croll Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats Exp. Neurol. 192 2 2005 348 356 10.1016/j.expneurol.2004.11.016
170. H.E. Scharfman Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor J. Neurophysiol. 78 2 1997 1082 1095
171. T.W. Scheewe, F.J. Backx, T. Takken, F. Jorg, A.C. van Strater, A.G. Kroes, and W. Cahn Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial Acta Psychiatr. Scand. 127 6 2013 464 473 10.1111/acps.12029
172. D.A. Schmid, T. Yang, M. Ogier, I. Adams, Y. Mirakhur, Q. Wang, and D.M. Katz A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome J. Neurosci. 32 5 2012 1803 1810 10.1523/JNEUROSCI.0865-11.2012
173. H. Schroeter, C. Boyd, J.P. Spencer, R.J. Williams, E. Cadenas, and C. Rice-Evans MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide Neurobiol. Aging 23 5 2002 861 880
174. S. Semaan, J. Wu, Y. Gan, Y. Jin, G.H. Li, J.F. Kerrigan, and Y. Huang Hyperactivation of BDNF-TrkB signaling cascades in human hypothalamic hamartoma (HH): a potential mechanism contributing to epileptogenesis CNS Neurosci. Ther. 21 2 2015 164 172 10.1111/cns.12331
175. A. Sharma, and S.R. Shaw Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis J. Pediatr. Health Care 26 4 2012 291 299 10.1016/j.pedhc.2011.02.008
176. E. Shimizu, K. Hashimoto, H. Watanabe, N. Komatsu, N. Okamura, K. Koike, and M. Iyo Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls Neurosci. Lett. 351 2 2003 111 114
177. H. Silver, N. Mandiuk, R. Einoch, E. Susser, L. Danovich, W. Bilker, and O. Weinreb Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients Int. Clin. Psychopharmacol. 30 3 2015 158 166 10.1097/YIC.0000000000000070
178. A.N. Sokolov, M.A. Pavlova, S. Klosterhalfen, and P. Enck Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior Neurosci. Biobehav. Rev. 37 10 Pt 2 2013 2445 2453 10.1016/j.neubiorev.2013.06.013
179. I. Solanki, P. Parihar, M.L. Mansuri, and M.S. Parihar Flavonoid-based therapies in the early management of neurodegenerative diseases Adv. Nutr. 6 1 2015 64 72 10.3945/an.114.007500
180. X. Song, X. Fan, X. Li, D. Kennedy, L. Pang, M. Quan, and L. Lv Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naive, first episode schizophrenia Schizophr. Res. 159 1 2014 51 55 10.1016/j.schres.2014.07.033
181. X. Song, M. Quan, L. Lv, X. Li, L. Pang, D. Kennedy, and X. Fan Decreased cortical thickness in drug naive first episode schizophrenia: in relation to serum levels of BDNF J. Psychiatr. Res. 60 2015 22 28 10.1016/j.jpsychires.2014.09.009
182. M. Sotiropoulou, C. Mantas, P. Bozidis, M. Marselos, V. Mavreas, T. Hyphantis, and K. Antoniou BDNF serum concentrations in first psychotic episode drug-naive schizophrenic patients: associations with personality and BDNF Val66Met polymorphism Life Sci. 92 4-5 2013 305 310 10.1016/j.lfs.2013.01.008
183. J.P. Spencer Flavonoids: modulators of brain function? Br. J. Nutr. 99 2008 ES60 77 10.1017/S0007114508965776 E Suppl. 1
184. J.P. Spencer Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance Proc. Nutr. Soc. 67 2 2008 238 252 10.1017/S0029665108007088
185. H.H. Stassen, J. Angst, and A. Delini-Stula Delayed onset of action of antidepressant drugs? Survey of recent results Eur. Psychiatry 12 4 1997 166 176 10.1016/S0924-9338(97)89100-6
186. C. Strohmaier, B.D. Carter, R. Urfer, Y.A. Barde, and G. Dechant A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor EMBO J. 15 13 1996 3332 3337
187. M. Suttie, T. Foroud, L. Wetherill, J.L. Jacobson, C.D. Molteno, E.M. Meintjes, and P. Hammond Facial dysmorphism across the fetal alcohol spectrum Pediatrics 131 3 2013 e779 788 10.1542/peds.2012-1371
188. A. Tabuchi Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function Biol. Pharm. Bull. 31 3 2008 327 335
189. A. Taliou, E. Zintzaras, L. Lykouras, and K. Francis An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders Clin. Ther. 35 5 2013 592 602 10.1016/j.clinthera.2013.04.006
190. Y.L. Tan, D.F. Zhou, L.Y. Cao, Y.Z. Zou, and X.Y. Zhang Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics Neurosci. Lett. 382 1-2 2005 27 32 10.1016/j.neulet.2005.02.054
191. J. Tanaka, Y. Horiike, M. Matsuzaki, T. Miyazaki, G.C. Ellis-Davies, and H. Kasai Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines Science 319 5870 2008 1683 1687 10.1126/science.1152864
192. R. Taurines, M. Segura, M. Schecklmann, L. Albantakis, E. Grunblatt, S. Walitza, and M. Gerlach Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder J. Neural Transm. 121 9 2014 1117 1128 10.1007/s00702-014-1162-x
193. T.C. Theoharides, S. Asadi, and S. Panagiotidou A case series of a luteolin formulation (NeuroProtek(R)) in children with autism spectrum disorders Int. J. Immunopathol. Pharmacol. 25 2 2012 317 323
194. H. Thoenen Neurotrophins and activity-dependent plasticity Prog. Brain Res. 128 2000 183 191 10.1016/S0079-6123(00)28016-3
195. M. Thompson Ray, C.S. Weickert, E. Wyatt, and M.J. Webster Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders J. Psychiatry Neurosci. 36 3 2011 195 203 10.1503/jpn.100048
196. K. Toyooka, K. Asama, Y. Watanabe, T. Muratake, M. Takahashi, T. Someya, and H. Nawa Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients Psychiatry Res. 110 3 2002 249 257
197. B.G. Travers, P.M. Tromp do, N. Adluru, N. Lange, D. Destiche, C. Ennis, and A.L. Alexander Atypical development of white matter microstructure of the corpus callosum in males with autism: a longitudinal investigation Mol. Autism 6 2015 15 10.1186/s13229-015-0001-8
198. S.J. Tsai TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism Med. Hypotheses 66 1 2006 173 175 10.1016/j.mehy.2005.05.033
199. R. Uher, A. Farmer, N. Henigsberg, M. Rietschel, O. Mors, W. Maier, and K.J. Aitchison Adverse reactions to antidepressants Br. J. Psychiatry 195 3 2009 202 210 10.1192/bjp.bp.108.061960
200. C.N. Ulleland The offspring of alcoholic mothers Ann. N. Y. Acad. Sci. 197 1972 167 169
201. N. Uppal, B. Wicinski, J.D. Buxbaum, H. Heinsen, C. Schmitz, and P.R. Hof Neuropathology of the anterior midcingulate cortex in young children with autism J. Neuropathol. Exp. Neurol. 73 9 2014 891 902 10.1097/NEN.0000000000000108
202. D. Vancampfort, M. De Hert, J. Knapen, M. Wampers, H. Demunter, S. Deckx, and M. Probst State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study Disabil. Rehabil. 33 8 2011 684 689 10.3109/09638288.2010.509458
203. R. Vanhala, L. Korhonen, M. Mikelsaar, D. Lindholm, and R. Riikonen Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome J. Child. Neurol. 13 9 1998 429 433
204. C.S. Weickert, T.M. Hyde, B.K. Lipska, M.M. Herman, D.R. Weinberger, and J.E. Kleinman Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia Mol. Psychiatry 8 6 2003 592 610 10.1038/sj.mp.4001308
205. C.S. Weickert, D.L. Ligons, T. Romanczyk, G. Ungaro, T.M. Hyde, M.M. Herman, and J.E. Kleinman Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia Mol. Psychiatry 10 7 2005 637 650 10.1038/sj.mp.4001678
206. R. Wierzejska Tea and health-a review of the current state of knowledge Przegl. Epidemiol. 68 3 2014 501 506 595-509
207. M.A. Wright, and A.B. Ribera Brain-derived neurotrophic factor mediates non-cell-autonomous regulation of sensory neuron position and identity J. Neurosci. 30 43 2010 14513 14521 10.1523/JNEUROSCI.4025-10.2010
208. C.H. Wu, T.H. Hung, C.C. Chen, C.H. Ke, C.Y. Lee, P.Y. Wang, and S.F. Chen Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling PLoS One 9 11 2014 e113397 10.1371/journal.pone.0113397
209. M.H. Xiu, L. Hui, Y.F. Dang, T.D. Hou, C.X. Zhang, Y.L. Zheng, and X.Y. Zhang Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics Prog. Neuropsychopharmacol. Biol. Psychiatry 33 8 2009 1508 1512 10.1016/j.pnpbp.2009.08.011
210. S.L. Xu, C.W. Bi, R.C. Choi, K.Y. Zhu, A. Miernisha, T.T. Dong, and K.W. Tsim Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor Evid. Based Complement. Altern. Med. 2013 2013 127075 10.1155/2013/127075
211. Y.J. Yang, Y.K. Li, W. Wang, J.G. Wan, B. Yu, M.Z. Wang, and B. Hu Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia Pharmacol. Biochem. Behav. 122 2014 30 36 10.1016/j.pbb.2014.03.013
212. R.Q. Yao, D.S. Qi, H.L. Yu, J. Liu, L.H. Yang, and X.X. Wu Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway Neurochem. Res. 37 12 2012 2777 2786 10.1007/s11064-012-0871-5
213. D.Y. Yoo, J.H. Choi, W. Kim, S.M. Nam, H.Y. Jung, J.H. Kim, and I.K. Hwang Effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia model Neurol. Res. 35 8 2013 813 820 10.1179/1743132813Y.0000000217
214. R. Yoshimura, H. Hori, A. Ikenouchi-Sugita, W. Umene-Nakano, A. Katsuki, K. Hayashi, and J. Nakamura Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients Hum. Psychopharmacol. 27 1 2012 33 38 10.1002/hup.1257
215. R. Zhang, K.A. Kang, M.J. Piao, D.O. Ko, Z.H. Wang, W.Y. Chang, and J.W. Hyun Preventive effect of 7,8-dihydroxyflavone against oxidative stress induced genotoxicity Biol. Pharm. Bull. 32 2 2009 166 171
216. T. Zigova, V. Pencea, S.J. Wiegand, and M.B. Luskin Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb Mol. Cell Neurosci. 11 4 1998 234 245 10.1006/mcne.1998.0684
217. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, L. Conti, and E. Cattaneo Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 5529 2001 493 498 10.1126/science.1059581